Skip to main content

Omnitek Engineering Corp

For the period ended Mar 31, 2025. Filed May 20, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 20, 2025

OMTKStored price and day change unavailable

What changed in Management’s Discussion and Analysis?

Read the current filing

Previous report: 10-Q

Period ended 2024-09-30; filed 2024-11-14.

0001096906-24-002123

Item 2. Management's Discussion and Analysis of the Financial Condition and Results of Operations

Current report: 10-Q

Period ended 2025-03-31; filed 2025-05-20.

0001096906-25-000867

Item 2. Management's Discussion and Analysis of the Financial Condition and Results of Operations

The baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.

Compared 51 previous paragraphs and 42 current paragraphs.

25 unchanged; 11 reworded; 6 added; 14 removed; 1 previous and 0 current paragraphs rearranged.

Tables are not compared: 0 previous and 0 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.

A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.

Added paragraphs (6)

Current report

Revenues were $359,746 for the three months ended March 31, 2025, compared with $237,077 for the three months ended March 31, 2024, an increase of $122,669.

Current report

For the three months ended March 31, 2025, total cost of goods sold was $218,778, for a gross margin of $140,968, compared with $153,358 and a gross margin of $83,719 for the three months ended March 31, 2024.

Current report

Gross margin as a percentage of sales for the three months ended March 31, 2025, was 39%, compared with 35% for the three months ended March 31, 2024.

Current report

In November 2023, the FASB issued ASU 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures", which amends the disclosure to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses on an annual and interim basis for to enable investors to develop more decision-useful financial analyses. All public entities will be required to report segment information in accordance with the new guidance starting in annual periods beginning after December 15, 2023. The Company is currently assessing potential impacts of ASU 2023-06 and does not expect the adoption of this guidance will have a material impact on its financial statements and disclosures.

Current report

In December 2023, the FASB issued ASU 2023-09, " Income Taxes (Topic 740): Improvements to Income Tax Disclosures", which amends the disclosure to address investor requests for more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information and includes certain other amendments to improve the effectiveness of income tax disclosures. For entities other than public business entities, the requirements will be effective for annual periods beginning after December 15, 2025. The guidance will be applied on a prospective basis with the option to apply the standard retrospectively. Early adoption is permitted. The Company is currently assessing potential impacts of ASU 2023-09 and does not expect the adoption of this guidance will have a material impact on its financial statements and disclosures and the Company is in a loss position and not incurring any tax expenses.
Removed paragraphs (14)

Previous report

For the three-month period ended September 30, 2024 andSeptember 30, 2023

Previous report

Revenues were $277,365 for the three-month period ended September 30, 2024 compared with $235,379 for the same period the prior year, an increase of $41,986. The increase in revenues for the period is primarily attributable to increased export sales.

Previous report

Cost of sales was $156,074 for the three-month period ended September 30, 2024 compared with $133,043 for the same period the prior year, an increase of $23,031. Our gross margin percentage was 44% for the three-month period ended September 30, 2024 compared with 43% in the same period a year earlier.

Previous report

Operating expenses for the three-month period ended September 30, 2024 were $149,694 compared with $149,700 in the same period a year ago, a decrease of $6. General and administrative expense for the three-month period ended September 30, 2024 was $131,072 compared with $131,199 for the same period the prior year. Major components of general and administrative expenses for the three-month period ended September 30, 2024 were professional fees of $14,588, rent expense of $10,695, and salaries and wages of $56,951. This compares with professional fees of $16,677, rent expense of $10,869 and salaries and wages of $56,851 for the same prior- year period. For the three-month period ended September 30, 2024 research and development expense was $17,658 compared with $18,065 for the same period last year.

Previous report

For the nine months ended September 30, 2024 andSeptember 30, 2023

Previous report

Our revenues were $781,412 for the nine months period ended September 30, 2024, compared with $712,303 for the same period in the prior year, an increase of $16,327 or 10%. The increase in revenues for the period is primarily attributable to increased exports sales.

Previous report

Our cost of sales was $465,602 for the nine months period ended September 30, 2024, compared with $413,718 a year earlier, an increase of $51,884. Our gross margin was 40% for the nine months ended September 30, 2024 compared with 42% last year. The change in gross margin between the periods relates primarily to product mix.

Previous report

Our net loss for the nine months period ended September 30, 2024 was $207,655 or ($0.01) per share, compared with a net loss of $171,474, or ($0.01) per share, in the prior year.

Previous report

We realized negative cash flow from investing activities of $6,335 for the nine months period ended September 30, 2024 compared with negative cash flow from investing activities of $0 for the same period in the prior year. The negative cash flow for the period ended September 30, 2024 related to purchases of fixed assets.
Reworded paragraphs (11)

Previous wording

Our operating expenses for the nine months period ended September 30, 2024 were $507,839 compared with $470,358 for the same period in the prior year, an increase of $37,481 or 8%. General and administrative expense for the nine months ended September 30, 2024 was $451,716 compared with $417,848 for the same period in 2023. Major components of general and administrative expenses for the nine months ended September 30, 2024 were professional fees of $68,485, rent expense of $32,344 and salaries and wages of $171,083. This compares with professional fees of $79,647, rent expense of 32,787, and salaries and wages of $170,054 for the same period a year ago. Research and development expense was $53,758 for the nine months ended September 30, 2024 compared with $51,201 last year.

Current wording

Operating expenses for the three months ended March 31, 2025, were $151,724 compared with $144,952 for the three months ended March 31, 2024, an increase of $6,772. General and administrative expense for the three months ended March 31, 2025, was $132,451 compared with $126,045 for the three months ended March 31, 2024. Major components of general and administrative expenses for the three months ended March 31, 2025, were professional fees of $18,918, rent expense of $10,430 and salary and wages of $55,861. This compares with professional fees of $13,975, rent expense of $10,825, and salary and wages of $57,030 for the three months ended March 31, 2024. For the three months ended March 31, 2025, research and development outlays were $18,309, compared with $18,471 for the three months ended March 31, 2024.

Previous wording

Our net loss for the three-month period ended September 30, 2024 was $32,841, or ($0.00) per share, compared with a net loss of $34,717, or ($0.00) per share, for the same period a year ago.

Current wording

Our net loss for the three months ended March 31, 2025, was $26,660, or ($0.00) per share, compared with a net loss of $66,458, or ($0.00) per share, for the three months ended March 31, 2024. The decreased net loss was primarily due to an uptick in filter sales.

Previous wording

Results for the three-month period ended September 30, 2024 reflect the impact of non-cash expenses, including the value of options and warrants granted in the amount of $353 and depreciation and amortization of $964. For the same period in the prior year, non-cash expenses included options and warrants granted in the amount of $2,619 and depreciation and amortization of $436.

Current wording

Results for the three months ended March 31, 2025, reflect the impact of non-cash expenses, including the value of options and warrants granted in the amount of $345, and depreciation and amortization of $964. For the three months period ended March 31, 2024, non-cash expenses included options and warrants granted in the amount of $1,963, and depreciation and amortization of $436.

Previous wording

At September 30, 2024, our current liabilities totaled $2,063,174 and our current assets totaled $733,846 resulting in negative working capital of $1,329,328.

Current wording

At March 31, 2025, our current liabilities totaled $2,185,534 and our current assets totaled $855,053, resulting in negative working capital of $1,330,481.

Previous wording

We have historically incurred significant losses, which have resulted in a total accumulated deficit of $22,068,002 at September 30, 2024.

Current wording

We have historically incurred significant losses, which have resulted in a total accumulated deficit of $22,054,144 at March 31, 2025.

Previous wording

We realized a negative cash flow from operations of $26,295 for the nine months period ended September 30, 2024, compared with a negative cash flow of $64,332 during the same period the prior year.

Current wording

We realized a negative cash flow from operations of $109,115 for the three months ended March 31, 2025 compared with a negative cash flow of $53,499 during the three months ended March 31, 2024.

Previous wording

Included in the operating loss of $192,029 for the nine-month period ended September 30, 2024 are non-cash expenses, which are not a drain on our capital resources. During this period, these non-cash expenses included the value of options granted in the amount of $5,010 and depreciation and amortization of $2,365. Additionally, the operating loss included general and administrative expenses of $451,716 and research and development expenses of $53,758.

Current wording

Included in the operating loss of $26,660 for the three months ended March 31, 2025, are non-cash expenses, which are not a drain on our capital resources. During the period, these non-cash expenses include the value of options and warrants granted in the amount of $345 and depreciation and amortization of $964. Additionally, the operating loss included general and administrative expenses of $132,451 and research and development expenses of $18,309.

Previous wording

We realized a $0.00 cash flow from financing activities for the nine months ended September 30, 2024 compared with positive cash flow of $15,113 for the same period the prior year. The positive cash flow for the same period in the prior year was due to proceeds from related party note payable.

Current wording

We realized $50,500 cash flow from financing activities for the three months ended March 31, 2025, compared to $0.00 cash flow for the three months ended March 31, 2024.

Previous wording

Inventories are stated at the lower of market or average cost basis. The Company reviews inventories on hand at least annually and records provisions for estimated excess, slow moving and obsolete inventory, as well as inventory with a carrying value in excess of net realizable value. The regular and systematic inventory valuation reviews include a current assessment of future product demand, historical experience and product expiration. Accordingly, the Company has established an allowance for the cost of such obsolete inventory.

Current wording

Inventories are stated at the lower of Net realizable value or average cost basis, cost determined on an average cost basis. Market value for raw materials is based on replacement costs. The Company reviews inventories on hand at least annually and records provisions for estimated excess, slow moving and obsolete inventory, as well as inventory with a carrying value in excess of net realizable value. The regular and systematic inventory valuation reviews include a current assessment of future product demand, historical experience and product expiration. Accordingly, the Company has established an allowance for the cost of such obsolete inventory.

Previous wording

The Company assesses the recoverability of its long-lived assets annually and whenever circumstances indicate that there may be an impairment. The Company compares the estimated undiscounted future cash flows to the carrying value of the long-lived assets to determine if impairment has occurred. In the event that impairment has occurred, the Company recognizes the impairment immediately.

Current wording

The Company assesses the recoverability of its long-lived assets annually and whenever circumstances indicate that there may be an impairment. The Company compares the estimated undiscounted future cash flows to the carrying value of the long-lived assets to determine if an impairment has occurred. In the event that an impairment has occurred, the Company recognizes the impairment immediately.

Previous wording

Products - The Company recognizes revenue from the sale of products as performance obligations are satisfied. Those sales predominantly contain a single delivery element, and revenue is recognized at a single point in time when ownership and risks transfer (i.e. the performance obligation has been satisfied). In general, ownership and risk passes FOB shipping point, or as negotiated.

Current wording

Products - The Company recognizes revenue from the sale of products as performance obligations are satisfied. This type of revenue is primarily generated from the sale of finished products to customers. Those sales predominantly contain a single delivery element and revenue is recognized at a single point in time when ownership, risks and rewards transfer. Upon fulfilment of the performance obligation, the customer is provided an invoice demonstrating transfer of control to the customer. Control passes FOB shipping point.
Rearranged previous paragraphs (1)

Previous report — wording carried elsewhere

Results for the nine months period ended September 30, 2024 reflect the impact of non-cash expenses, including the value of options and warrants granted in the amount of $5,010 and depreciation and amortization of $2,365. For the nine-month period in the prior-year, non-cash expenses included the value of options and warrants granted of $13,157 and depreciation and amortization of $1,309.